Comparison of low-dose versus standard-dose colony stimulating factor in patients with chemotherapy-induced febrile neutropenia

Oncology

Volumn 65, Issue 3, 2003, Pages 283-284

  Burney, Ikram A ^a   Salam, Abdul ^a   Jat, Afzal A ^a   Iqbal, M Perwaiz ^a   Siddiqui, Tariq ^a   Khan, Mohammad A ^a   Smego Jr , Raymond A ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEBRILE NEUTROPENIA; HOSPITALIZATION; HUMAN; INFECTION PREVENTION; LABORATORY TEST; LETTER; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SOLID TUMOR;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEVER; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; MIDDLE AGED; NEOPLASMS; NEUTROPENIA; PROSPECTIVE STUDIES;

EID: 0344737847     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000070311     Document Type: Letter

References (7)

1. Brandt SJ, Peters WP, Atwater SK, et al: Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. N Eng J Med 1988;318:869-876.
2. Vadhan-Raj S, Buescher S, LeMaistre A, et al: Stimulation of hematopoiesis in patients with bone marrow failure and in patients with malignancy by recombinant human granulocyte-macrophage colony-stimulating factor. Blood 1988;72:134-141.
3. Ikeda K, Tasaka T, Sasaki K, Murata M, Kitanaka A, Nagai M, et al: Low-dose continuous subcutaneous infusion of granulocyte colony stimulating factor for chemotherapy-induced neutropenia in acute myelogenous leukemia and its pharmacokinetics. Leukemia 1994;8:1838-1841.
4. Chang MC, Lai GM, Tsan KW, Wang RS, Wu JH: Clinical trial of low-dose rHuG-CSF in neutropenic cancer patients following anti-cancer chemotherapy. J Formos Med Assoc 1996; 95:845-850.
5. Toner GC, Shapiro JD, Laidlaw CR, et al: Low-dose versus standard-dose lenograstim prophylaxis after chemotherapy: A randomized crossover comparison. J Clin Oncol 1998;16:3874-3879.
6. Shimazaki C, Oku N, Uchiyama H, et al: Effect of granulocyte colony-stimulating factor on hematopoietic recovery after peripheral blood progenitor cell transplantation. Bone Marrow Transplant 1994;13:271-275.
7. McQuaker IG, Hunter AE, Pacey S, Haynes AP, Iqbal A, Russel NH: Low-dose filgrastim significantly enhances neutrophil recovery following autologous peripheral-blood stem-cell transplantation in patients with lymphoproliferative disorders: Evidence for clinical and economic benefit. J Clin Oncol 1997;15:451-457.